Daily Archive: November 11, 2011

Nov 11

Facts and figures in cardiology

Less than 15% patients with CKD have their blood pressure controlled to <130/80 mm Hg despite of the use on average of 3 different antihypertensive agents

Nov 11

Echo should be done when suspecting rheumatic fever

Rheumatic heart disease is still a common cause of morbidity and mortality in India. One third of patients with carditis are detected by echo only and so echo should be included in diagnostic criteria for acute rheumatic fever, as per a report from Dr Rajeev Bhardwaj from IGMC Shimla, who will be presenting his data …

Continue reading »

Nov 11

FDA Safety Communication on Fenofibrate

The US FDA has issued a safety communication on cholesterol-lowering agent fenofibric acid, stating that the drug may not lower the risk of major cardiovascular events [1] based on ACCORD Lipid trial, in which the combination of fenofibrate plus simvastatin was compared with simvastatin alone in patients with type 2 diabetes mellitus. There was no …

Continue reading »

Nov 11

CABG, PCI Guidelines Stress Collaboration

A multidisciplinary heart team — including an interventional cardiologist and a cardiac surgeon — should work together to develop a care plan for each patient with coronary artery disease, according to updated guidelines from the American College of Cardiology Foundation and the American Heart Association and published in the Dec. 6 issue of the Journal …

Continue reading »

Nov 11

TCT Update:Platelet Testing in PCI no use in day to day practice

‘Platelet function testing in patients with stable coronary artery disease undergoing percutaneous coronary intervention (PCI) may have little clinical utility in routine practice. At 3o days, the absolute and relative levels of platelet inhibition in response to adenosine diphosphate (ADP) P2Y12 receptor antagonists as assessed by the Verify Now P2Y12 test were independent predictors of …

Continue reading »